The treatment landscape for MS has expanded over
the past 20 years and will likely undergo further expansion
over the next several years. Although new
treatments have shown efficacy in relapse reduction
and MRI outcomes, treatment side effects and potential
risks associated with these treatments will become
important points of discussion with patients. Treatments
continue to be directed toward the inflammatory
response seen in MS, with outcomes of relapse
reduction and reduction in new MRI activity. Some
also show a positive effect on progression of disability
and may have neuroprotective properties.